Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
The D.C. Lung Cancer Conference 2026, organized by MedStar Health, will take place on 10 October 2026, from 7:00 AM to 9:00 PM, at the JW Marriott in Washington, D.C. The one-day multidisciplinary meeting will provide clinicians with a comprehensive update on recent advances across the lung cancer care continuum, from screening and diagnosis to […]
